Spanish Red Biotech Pipeline

Oryzon

Iadademstat (ORY-1001) - Selective LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: ED-SCLC 1L Clinical Trial "STELLAR" (Combo with ICI) In preparation IND 1H22 7 FPI 2H22
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical